SEIA
DNA icon

Signature Estate & Investment Advisors’s Ginkgo Bioworks DNA Stock Holding History

Signature Estate & Investment Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-350
Closed -$24K – 181
2023
Q4 		$24K Buy
+350
New +$21.4K ﹤0.01% 180

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Signature Estate & Investment Advisors's DNA Position: Q1 2024 in Review

Signature Estate & Investment Advisors sold out of Ginkgo Bioworks (DNA) in Q1 2024, closing a stake of 350 shares — an estimated $24K sold.

Signature Estate & Investment Advisors first reported a position in DNA in Q4 2023 and held it in 1 quarter. The position peaked at $24K in Q4 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

  • Signature Estate & Investment Advisors reported no remaining Ginkgo Bioworks position as of Q1 2024 after selling out during the quarter.
  • Signature Estate & Investment Advisors sold 350 Ginkgo Bioworks shares in Q1 2024, an estimated $24K.
  • Signature Estate & Investment Advisors first reported a position in Ginkgo Bioworks in Q4 2023 and held it in 1 quarter.
  • Signature Estate & Investment Advisors's Ginkgo Bioworks position peaked at $24K in Q4 2023.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on Signature Estate & Investment Advisors's 13F filing for Q1 2024, filed 13 May 2024.